Altimmune (ALT) CFO Gregory Weaver Buys 1,753 Shares via ESPP

What Happened

Gregory L. Weaver, Chief Financial Officer of Altimmune, acquired 1,753 shares of Altimmune common stock on July 31, 2026 through the company's Employee Stock Purchase Plan (ESPP). The purchase price reported was $2.41 per share, for a total cost of approximately $4,232. This is an acquisition (code A) under the ESPP rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-31; Form 4 filed: 2026-08-03 (filed within required 2 business days — timely).
• Price: $2.41 per share; Total value: ~$4,232.
• Shares acquired: 1,753 shares.
• Shares owned after transaction: not disclosed in the provided filing.
• Footnotes:
  • F1: Purchase was through the Issuer's 2019 ESPP for the Feb 1, 2026 – Jul 31, 2026 purchase period.
  • F2: Shares were purchased at 85% of the closing price on July 31, 2026 (ESPP discount).
• Transaction code: A (award/acquisition via ESPP).

Context

ESPP purchases are a routine employee benefit that allow insiders to buy company stock at a discount (here, 85% of the closing price). Such purchases show participation in the company plan but are not, by themselves, definitive signals of insider sentiment.